Peter Beck, Kerryn Beck, Warren Butler, Equatorial Trust and Peek Street Equatorial Trustee Limited reported a series of sales of Rocket Lab Corp (RKLB) common stock on September 15 and 16, 2025. The filings show multiple disposals executed under a Rule 10b5-1 trading plan adopted by the Equatorial Trust on June 13, 2025, with weighted average prices disclosed for groups of sales ranging from about $47.41 to $55.16 per share.
The Form 4s disclose that the shares are held directly by the Trust and that Peek Street Equatorial Trustee Limited is the trustee, with Peter Beck, Kerryn Beck and Warren Butler serving as directors of the Trustee and sharing voting and investment control; each is therefore deemed an indirect beneficial owner. Following the reported transactions, the Trust’s reported indirect beneficial ownership is shown as 2,500,000 shares in the most recent line item.
Rocket Lab Corp (RKLB) submitted a Form 144 notice reporting a proposed sale of 4,286 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 09/17/2025. The filer reports the 4,286 shares were acquired as Restricted Stock Units from the issuer on 08/22/2025 and the aggregate market value of the proposed sale is listed as $202,492.07. The filing shows 479,355,713 shares outstanding for the issuer. The notice states there were no other sales by the reporting person in the prior three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice for Rocket Lab Corp (RKLB): The filing indicates a proposed sale of 9,416 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $444,858.92. The shares are scheduled for sale on 09/17/2025 on NASDAQ. The securities were acquired on 08/22/2025 as Restricted Stock Units from the issuer, with payment recorded on 08/22/2025. The filing reports 479,355,713 shares outstanding and states there were no securities sold in the past three months by the account. Several standard form sections (filer identification and issuer address/contact fields) appear blank in the provided content.
Rocket Lab Corp (RKLB) filed a Form 144 reporting a proposed sale of 68,254 common shares with an aggregate market value of $3,342,091.24. The notice lists the approximate sale date as 09/16/2025 on NASDAQ. The shares to be sold were acquired through restricted stock vesting on 09/15/2025, with a total of 114,845 shares acquired and payment noted as compensation. The filing states there were no securities sold by the person in the past three months. The notice includes the signers representation that they are not aware of any undisclosed material adverse information about the issuer.
Rocket Lab Corp (RKLB) filed a Form 144 reporting a proposed sale of 45,535 common shares through Morgan Stanley Smith Barney on 09/16/2025 on the NASDAQ, with an aggregate market value of $2,229,648.60. The securities were acquired on 09/15/2025 via restricted stock vesting from the issuer and were paid as compensation. The filer reports no other sales in the past three months and affirms they have no undisclosed material adverse information about the issuer.
Rocket Lab Corp (RKLB) filed a Form 144 reporting proposed sales of Common stock by a person whose restricted shares vested on 09/15/2025. The filing lists two proposed sales through Morgan Stanley Smith Barney LLC: 22,991 shares (aggregate market value $1,125,768.11) and 8,194 shares (aggregate market value $401,224.13), both planned for sale on 09/16/2025 on NASDAQ. The filer states the shares were acquired by restricted stock vesting from the issuer on 09/15/2025 and that payment was compensation. No securities were reported sold by the person in the past three months in this filing.
Form 144 filing for Rocket Lab Corp (RKLB) reports a proposed sale of 2,500,000 shares of Class A common stock, with an aggregate market value of $135,100,000. The securities were acquired on 08/25/2021 through conversion from preferred shares received in a business combination with the issuer. The planned approximate sale date is 09/15/2025 and the broker named is Goldman Sachs & Co. LLC on the NASD. No securities were sold by the filer in the past three months, and the filer states they are unaware of any undisclosed material adverse information. Other identifying details for the filer and issuer are not provided in the form content supplied.
Rocket Lab Corporation entered into an ATM Equity Offering Sales Agreement that allows it to offer and sell, from time to time, shares of its common stock having an aggregate offering price of up to $750,000,000. The shares will be sold through or to a group of sales agents, including BofA Securities, Cantor Fitzgerald, BTIG, KeyBanc Capital Markets, Citizens JMP Securities, Needham & Company, and Roth Capital Partners, under an existing shelf registration statement and related prospectus supplement.
The company is not required to sell any shares under this agreement, and the sales agents have agreed to use commercially reasonable efforts to conduct sales in line with Rocket Lab’s instructions. Either Rocket Lab or the sales agents may terminate the agreement at any time upon written notice.
Amendment No. 7 to a Schedule 13D reports ownership details for Rocket Lab Corporation (RKLB). The filing shows that Vinod Khosla, VK Services, and affiliated Khosla Ventures entities collectively hold significant common stock positions originally acquired via conversion of Legacy Rocket Lab preferred stock in the 2021 business combination.
VK Services and Vinod Khosla are reported as beneficial owners of 43,433,056 shares (9.0% of the class) and Khosla Ventures V, L.P. directly holds 11,323,617 shares (2.3%). Between July 23, 2025 and September 2, 2025, KV V distributed a total of 8,000,000 shares pro rata to its partners, leaving VK Services with 32,109,439 directly owned shares. The Reporting Persons state the shares are held solely for investment and have no present plans to change Rocket Lab's business or governance. The KV Funds have registration rights, including demand registration for offerings of at least $50 million and piggyback rights.
Rocket Lab director Nina Armagno was granted 3,960 restricted stock units (RSUs) on 08/27/2025 under the company’s non-employee director compensation policy and 2021 incentive plan. The RSUs were reported at a $0.0 price and increase her beneficial ownership to 136,254 shares following the grant. The RSUs vest in full on the earlier of the issuer’s next annual meeting or the one-year anniversary of the grant, provided she remains in continuous service as a board member through the vesting date. The Form 4 was executed by an attorney-in-fact on behalf of Ms. Armagno on 08/29/2025.